These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 10566054

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Dofetilide. UK 68, UK 68798, Tikosyn, Xelide.
    Drugs R D; 1999 Apr; 1(4):304-11. PubMed ID: 10566050
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Tedisamil. KC 8857.
    Drugs R D; 1999 Apr; 1(4):327-30. PubMed ID: 10566055
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Diprafenone.
    Drugs R D; 1999 Apr; 1(4):301-3. PubMed ID: 10566049
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Pharmacology of the class III antiarrhythmic agent sematilide in patients with arrhythmias.
    Wong W, Pavlou HN, Birgersdotter UM, Hilleman DE, Mohiuddin SM, Roden DM.
    Am J Cardiol; 1992 Jan 15; 69(3):206-12. PubMed ID: 1731461
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Clinical potential of emerging antiarrhythmic agents.
    Capucci A, Aschieri D, Villani GQ, Piepoli MF.
    Drugs R D; 1999 Apr 15; 1(4):279-90. PubMed ID: 10566046
    [Abstract] [Full Text] [Related]

  • 12. Antiarrhythmic agents. Summary and table.
    Coleman SG, Dalton J.
    Drugs R D; 1999 Apr 15; 1(4):291-5. PubMed ID: 10566047
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Antiarrhythmic and proarrhythmic effects of sematilide in canine ventricular arrhythmia models.
    Xue YX, Eto K, Akie Y, Hashimoto K.
    Jpn J Pharmacol; 1996 Feb 15; 70(2):129-38. PubMed ID: 8866750
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Hemodynamic effects of intravenous sematilide in patients with congestive heart failure: a class III antiarrhythmic agent without cardiodepressant effects.
    Stambler BS, Gottlieb SS, Singh BN, Ramanathan KB, Ogilby JD, Ellenbogen KA.
    J Am Coll Cardiol; 1995 Dec 15; 26(7):1679-84. PubMed ID: 7594103
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.